7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C51H80N4O19S — CID 89201196

IUPAC7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
SMILESCO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@H](O[C@H]3O[C@@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)/C(=N\O)[C@@H](C)[C@H](O)[C@@](C)(O)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OS(=O)(=O)CCNCCCc1cc2c3c(c1)c(=O)c(C(=O)O)cn3COC2
InChIInChI=1S/C51H80N4O19S/c1-26-21-49(7,62)44(72-48-41(57)36(54(10)11)18-27(2)69-48)29(4)42(30(5)47(61)73-51(9,63)43(58)28(3)38(26)53-64)71-37-22-50(8,67-12)45(31(6)70-37)74-75(65,66)17-16-52-15-13-14-32-19-33-24-68-25-55-23-35(46(59)60)40(56)34(20-32)39(33)55/h19-20,23,26-31,36-37,41-45,48,52,57-58,62-64H,13-18,21-22,24-25H2,1-12H3,(H,59,60)/b53-38+/t26-,27+,28-,29+,30-,31+,36+,37+,41-,42+,43+,44+,45+,48-,49-,50-,51+/m1/s1
InChIKeyUYIAHZRYFOOWDE-JWXMDUJVSA-N
MW1085.28 g/mol
LogP2.30
Rot. Bonds16

About 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (PubChem CID 89201196) has the molecular formula C51H80N4O19S and a molecular weight of 1085.28 g/mol. Its IUPAC name is 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.

Molecular Properties

Compound Name7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
PubChem CID89201196
Molecular FormulaC51H80N4O19S
Molecular Weight1085.28 g/mol
Exact Mass1084.51
IUPAC Name7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid
SMILESCO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@H](O[C@H]3O[C@@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)/C(=N\O)[C@@H](C)[C@H](O)[C@@](C)(O)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OS(=O)(=O)CCNCCCc1cc2c3c(c1)c(=O)c(C(=O)O)cn3COC2
InChIInChI=1S/C51H80N4O19S/c1-26-21-49(7,62)44(72-48-41(57)36(54(10)11)18-27(2)69-48)29(4)42(30(5)47(61)73-51(9,63)43(58)28(3)38(26)53-64)71-37-22-50(8,67-12)45(31(6)70-37)74-75(65,66)17-16-52-15-13-14-32-19-33-24-68-25-55-23-35(46(59)60)40(56)34(20-32)39(33)55/h19-20,23,26-31,36-37,41-45,48,52,57-58,62-64H,13-18,21-22,24-25H2,1-12H3,(H,59,60)/b53-38+/t26-,27+,28-,29+,30-,31+,36+,37+,41-,42+,43+,44+,45+,48-,49-,50-,51+/m1/s1
InChIKeyUYIAHZRYFOOWDE-JWXMDUJVSA-N
XLogP2.30
TPSA313.13 Ų
H-Bond Donors7
H-Bond Acceptors22
Rotatable Bonds16
Heavy Atoms75
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001085.28
LogP ≤ 52.30
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'oxime_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'}

Analyze 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The IUPAC name of 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid (CID 89201196) is 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid.
What is the SMILES notation for 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The canonical SMILES for 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid is CO[C@]1(C)C[C@H](O[C@H]2[C@H](C)[C@H](O[C@H]3O[C@@H](C)C[C@H](N(C)C)[C@H]3O)[C@](C)(O)C[C@@H](C)/C(=N\O)[C@@H](C)[C@H](O)[C@@](C)(O)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OS(=O)(=O)CCNCCCc1cc2c3c(c1)c(=O)c(C(=O)O)cn3COC2.
What is the InChIKey of 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
The InChIKey is UYIAHZRYFOOWDE-JWXMDUJVSA-N. The full InChI is InChI=1S/C51H80N4O19S/c1-26-21-49(7,62)44(72-48-41(57)36(54(10)11)18-27(2)69-48)29(4)42(30(5)47(61)73-51(9,63)43(58)28(3)38(26)53-64)71-37-22-50(8,67-12)45(31(6)70-37)74-75(65,66)17-16-52-15-13-14-32-19-33-24-68-25-55-23-35(46(59)60)40(56)34(20-32)39(33)55/h19-20,23,26-31,36-37,41-45,48,52,57-58,62-64H,13-18,21-22,24-25H2,1-12H3,(H,59,60)/b53-38+/t26-,27+,28-,29+,30-,31+,36+,37+,41-,42+,43+,44+,45+,48-,49-,50-,51+/m1/s1.
What are the key properties of 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid?
7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid has a molecular weight of 1085.28 g/mol, XLogP of 2.30, 16 rotatable bonds, 7 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[3-[2-[(2S,3S,4R,6R)-6-[[(3R,4S,5S,6S,7R,9R,10E,11R,12S,13S)-6-[(2R,3R,4S,6S)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-7,12,13-trihydroxy-10-hydroxyimino-3,5,7,9,11,13-hexamethyl-2-oxo-oxacyclotridec-4-yl]oxy]-4-methoxy-2,4-dimethyloxan-3-yl]oxysulfonylethylamino]propyl]-10-oxo-3-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid is sourced from PubChem (CID 89201196), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).